Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 28;20(9):2094.
doi: 10.3390/ijms20092094.

Magnesium and Drugs

Affiliations
Review

Magnesium and Drugs

Uwe Gröber. Int J Mol Sci. .

Abstract

Several drugs including diuretics and proton-pump inhibitors can cause magnesium loss and hypomagnesemia. Magnesium and drugs use the same transport and metabolism pathways in the body for their intestinal absorption, metabolism, and elimination. This means that when one or more drug is taken, there is always a potential risk of interaction with the magnesium status. Consequently the action of a drug may be adversely affected by magnesium (e.g., magnesium, calcium, and zinc can interfere with the gastrointestinal absorption of tetracycline antibiotics) and simultaneously the physiological function of minerals such as magnesium may be impaired by a drug (e.g., diuretics induce renal magnesium loss). Given the ever-increasing number of drugs on the market and the frequency with which they are used, greater attention must be paid in daily medical and pharmaceutical practice focused in particular on the adverse effects of drug therapy on magnesium status in order to minimize the potential risk to the health of patients.

Keywords: Magnesium; SLC41A1; TRPM6; diuretics; drug-induced magnesium deficiency; drugs; proton-pump inhibitors.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Disruption of micronutrient status by drugs [9,10].
Figure 2
Figure 2
Electrolyte disorders by thiazides and loop diuretics [9,10,28].

References

    1. The 2018 Ageing Report 2018: Underlying Assumptions and Projection Methodologies. European Commission; Brussels, Belgium: Nov, 2017. [(accessed on 20 April 2019)]. p. 3. Institutional Paper 065. Available online: https://ec.europa.eu/info/sites/info/files/economy-finance/ip065_en.pdf.
    1. Hall M., Dondo T.B., Yan A.T., Mamas M.A., Timmis A.D., Deanfield J.E., Jernberg T., Hemingway H., Fox K.A.A., Gale C.P. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. PLoS Med. 2018;15:e1002501. doi: 10.1371/journal.pmed.1002501. - DOI - PMC - PubMed
    1. Barnett K., Mercer S.W., Norbury M., Watt G., Wyke S., Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet. 2012;380:37–43. doi: 10.1016/S0140-6736(12)60240-2. - DOI - PubMed
    1. Puth M.T., Klaschik M., Schmid M., Weckbecker K., Münster E. Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet. Disord. 2018;19:144. doi: 10.1186/s12891-018-2060-4. - DOI - PMC - PubMed
    1. Hofer-Dückelmann C. Gender and polypharmacotherapy in the elderly: A clinical challenge. Handb. Exp. Pharmacol. 2012;214:169–182. - PubMed

MeSH terms

LinkOut - more resources